Commission decisions on applications for authorisation

2022-11-09

The European Commission has granted 11 authorisations for uses of

4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)

(EC -, CAS -) (the expiry dates for the review period are in brackets):

  • four uses applied for by Zoetis Belgium S.A. (4 January 2031 and 4 January 2033);
  • two uses applied for by Delpharm Biotech (4 January 2033);
  • three uses applied for by Idexx Montpellier SAS (4 January 2033);
  • one use applied for by Idexx B.V. (4 January 2033); and
  • one use applied for by Instrumentation Laboratory SpA (4 January 2033).

The European Commission has granted two authorisations for uses of

4-Nonylphenol, branched and linear, ethoxylated (4-NPnEO)

(EC -, CAS -) (the expiry dates for the review period are in brackets):

  • one use applied for by Idexx Montpellier SAS (4 January 2033); and
  • one use applied for by Idexx B.V. (4 January 2033).

Read More

ECHA, 09-11-22
; https://echa.europa.eu/view-article/-/journal_content/title/9109026-225